Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002180 · ClinicalTrials.gov registry record · Phase 1

A Study of PMPA in HIV-Infected Patients

A Phase 1 study, sponsored by Gilead Sciences.

Completed
Registry status
Phase 1
Development phase

NCT00002180: Completed Phase 1 study, sponsored by Gilead Sciences.

NCT00002180 is a Phase 1 study that has completed, run by Gilead Sciences. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002180, a Phase 1 study, has completed, sponsored by Gilead Sciences.

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

The purpose of this study is to see if it is safe and effective to give PMPA to HIV-infected patients. This study also examines how the body handles PMPA.

Interventions

  • DRUG Tenofovir

Trial Details

FieldValue
Phase Phase 1
Gilead Sciences

504 total trials

What the finished NCT00002180 record still lists

NCT00002180 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Tenofovir is the first listed.

NCT00002180 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00002180 about?

NCT00002180 is a clinical study titled "A Study of PMPA in HIV-Infected Patients". The purpose of this study is to see if it is safe and effective to give PMPA to HIV-infected patients. This study also examines how the body handles PMPA.

What is the current status of trial NCT00002180?

This trial is currently completed. It is a Phase 1 study.

What interventions are being tested in trial NCT00002180?

The interventions under investigation include: Tenofovir (DRUG).

Who is sponsoring clinical trial NCT00002180?

This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Source: ClinicalTrials.gov NCT00002180, the US trial registry maintained by the National Library of Medicine. NCT00002180 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.